カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の第XIII因子濃縮物市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Factor XIII Concentrate Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19312）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19312
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：72
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の第XIII因子濃縮物市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

第XIII因子濃縮物市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の第XIII因子濃縮物の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

第XIII因子濃縮物市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・1000IU、1600IU

用途別セグメントは次のように区分されます。
・病院、診療所

世界の第XIII因子濃縮物市場の主要な市場プレーヤーは以下のとおりです。
・CSL Behring

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、第XIII因子濃縮物製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な第XIII因子濃縮物メーカーの企業概要、2019年～2022年までの第XIII因子濃縮物の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な第XIII因子濃縮物メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別第XIII因子濃縮物の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの第XIII因子濃縮物の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での第XIII因子濃縮物市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および第XIII因子濃縮物の産業チェーンを掲載しています。
・第13、14、15章では、第XIII因子濃縮物の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 第XIII因子濃縮物の概要
- 種類別分析（2017年vs2021年vs2028年）：1000IU、1600IU
- 用途別分析（2017年vs2021年vs2028年）：病院、診療所
- 世界の第XIII因子濃縮物市場規模・予測
- 世界の第XIII因子濃縮物生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- CSL Behring
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：1000IU、1600IU
・用途別分析2017年-2028年：病院、診療所
・第XIII因子濃縮物の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・第XIII因子濃縮物のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・第XIII因子濃縮物のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・第XIII因子濃縮物の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・第XIII因子濃縮物の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Factor XIII Concentrate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Factor XIII Concentrate market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Factor XIII Concentrate global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 1000IU segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Factor XIII Concentrate include CSL Behring, , , , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Factor XIII Concentrate market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
1000IU
1600IU
Market segment by Application can be divided into
Hospital
Clinic
The key market players for global Factor XIII Concentrate market are listed below:
CSL Behring
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Factor XIII Concentrate product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Factor XIII Concentrate, with price, sales, revenue and global market share of Factor XIII Concentrate from 2019 to 2022.
Chapter 3, the Factor XIII Concentrate competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Factor XIII Concentrate breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Factor XIII Concentrate market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Factor XIII Concentrate.
Chapter 13, 14, and 15, to describe Factor XIII Concentrate sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Factor XIII Concentrate Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Factor XIII Concentrate Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 1000IU
1.2.3 1600IU
1.3 Market Analysis by Application
1.3.1 Overview: Global Factor XIII Concentrate Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Factor XIII Concentrate Market Size & Forecast
1.4.1 Global Factor XIII Concentrate Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Factor XIII Concentrate Sales in Volume (2017-2028)
1.4.3 Global Factor XIII Concentrate Price (2017-2028)
1.5 Global Factor XIII Concentrate Production Capacity Analysis
1.5.1 Global Factor XIII Concentrate Total Production Capacity (2017-2028)
1.5.2 Global Factor XIII Concentrate Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Factor XIII Concentrate Market Drivers
1.6.2 Factor XIII Concentrate Market Restraints
1.6.3 Factor XIII Concentrate Trends Analysis
2 Manufacturers Profiles
2.1 CSL Behring
2.1.1 CSL Behring Details
2.1.2 CSL Behring Major Business
2.1.3 CSL Behring Factor XIII Concentrate Product and Services
2.1.4 CSL Behring Factor XIII Concentrate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Factor XIII Concentrate Breakdown Data by Manufacturer
3.1 Global Factor XIII Concentrate Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Factor XIII Concentrate Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Factor XIII Concentrate
3.4 Market Concentration Rate
3.4.1 Top 3 Factor XIII Concentrate Manufacturer Market Share in 2021
3.4.2 Top 6 Factor XIII Concentrate Manufacturer Market Share in 2021
3.5 Global Factor XIII Concentrate Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Factor XIII Concentrate Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Factor XIII Concentrate Market Size by Region
4.1.1 Global Factor XIII Concentrate Sales in Volume by Region (2017-2028)
4.1.2 Global Factor XIII Concentrate Revenue by Region (2017-2028)
4.2 North America Factor XIII Concentrate Revenue (2017-2028)
4.3 Europe Factor XIII Concentrate Revenue (2017-2028)
4.4 Asia-Pacific Factor XIII Concentrate Revenue (2017-2028)
4.5 South America Factor XIII Concentrate Revenue (2017-2028)
4.6 Middle East and Africa Factor XIII Concentrate Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Factor XIII Concentrate Sales in Volume by Type (2017-2028)
5.2 Global Factor XIII Concentrate Revenue by Type (2017-2028)
5.3 Global Factor XIII Concentrate Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Factor XIII Concentrate Sales in Volume by Application (2017-2028)
6.2 Global Factor XIII Concentrate Revenue by Application (2017-2028)
6.3 Global Factor XIII Concentrate Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Factor XIII Concentrate Sales by Type (2017-2028)
7.2 North America Factor XIII Concentrate Sales by Application (2017-2028)
7.3 North America Factor XIII Concentrate Market Size by Country
7.3.1 North America Factor XIII Concentrate Sales in Volume by Country (2017-2028)
7.3.2 North America Factor XIII Concentrate Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Factor XIII Concentrate Sales by Type (2017-2028)
8.2 Europe Factor XIII Concentrate Sales by Application (2017-2028)
8.3 Europe Factor XIII Concentrate Market Size by Country
8.3.1 Europe Factor XIII Concentrate Sales in Volume by Country (2017-2028)
8.3.2 Europe Factor XIII Concentrate Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Factor XIII Concentrate Sales by Type (2017-2028)
9.2 Asia-Pacific Factor XIII Concentrate Sales by Application (2017-2028)
9.3 Asia-Pacific Factor XIII Concentrate Market Size by Region
9.3.1 Asia-Pacific Factor XIII Concentrate Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Factor XIII Concentrate Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Factor XIII Concentrate Sales by Type (2017-2028)
10.2 South America Factor XIII Concentrate Sales by Application (2017-2028)
10.3 South America Factor XIII Concentrate Market Size by Country
10.3.1 South America Factor XIII Concentrate Sales in Volume by Country (2017-2028)
10.3.2 South America Factor XIII Concentrate Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Factor XIII Concentrate Sales by Type (2017-2028)
11.2 Middle East & Africa Factor XIII Concentrate Sales by Application (2017-2028)
11.3 Middle East & Africa Factor XIII Concentrate Market Size by Country
11.3.1 Middle East & Africa Factor XIII Concentrate Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Factor XIII Concentrate Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Factor XIII Concentrate and Key Manufacturers
12.2 Manufacturing Costs Percentage of Factor XIII Concentrate
12.3 Factor XIII Concentrate Production Process
12.4 Factor XIII Concentrate Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Factor XIII Concentrate Typical Distributors
13.3 Factor XIII Concentrate Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Factor XIII Concentrate Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Factor XIII Concentrate Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 4. CSL Behring Major Business
Table 5. CSL Behring Factor XIII Concentrate Product and Services
Table 6. CSL Behring Factor XIII Concentrate Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Global Factor XIII Concentrate Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 8. Global Factor XIII Concentrate Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 9. Market Position of Manufacturers in Factor XIII Concentrate, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 10. Global Factor XIII Concentrate Production Capacity by Company, (K Units): 2020 VS 2021
Table 11. Head Office and Factor XIII Concentrate Production Site of Key Manufacturer
Table 12. Factor XIII Concentrate New Entrant and Capacity Expansion Plans
Table 13. Factor XIII Concentrate Mergers & Acquisitions in the Past Five Years
Table 14. Global Factor XIII Concentrate Sales by Region (2017-2022) & (K Units)
Table 15. Global Factor XIII Concentrate Sales by Region (2023-2028) & (K Units)
Table 16. Global Factor XIII Concentrate Revenue by Region (2017-2022) & (USD Million)
Table 17. Global Factor XIII Concentrate Revenue by Region (2023-2028) & (USD Million)
Table 18. Global Factor XIII Concentrate Sales by Type (2017-2022) & (K Units)
Table 19. Global Factor XIII Concentrate Sales by Type (2023-2028) & (K Units)
Table 20. Global Factor XIII Concentrate Revenue by Type (2017-2022) & (USD Million)
Table 21. Global Factor XIII Concentrate Revenue by Type (2023-2028) & (USD Million)
Table 22. Global Factor XIII Concentrate Price by Type (2017-2022) & (US$/Unit)
Table 23. Global Factor XIII Concentrate Price by Type (2023-2028) & (US$/Unit)
Table 24. Global Factor XIII Concentrate Sales by Application (2017-2022) & (K Units)
Table 25. Global Factor XIII Concentrate Sales by Application (2023-2028) & (K Units)
Table 26. Global Factor XIII Concentrate Revenue by Application (2017-2022) & (USD Million)
Table 27. Global Factor XIII Concentrate Revenue by Application (2023-2028) & (USD Million)
Table 28. Global Factor XIII Concentrate Price by Application (2017-2022) & (US$/Unit)
Table 29. Global Factor XIII Concentrate Price by Application (2023-2028) & (US$/Unit)
Table 30. North America Factor XIII Concentrate Sales by Country (2017-2022) & (K Units)
Table 31. North America Factor XIII Concentrate Sales by Country (2023-2028) & (K Units)
Table 32. North America Factor XIII Concentrate Revenue by Country (2017-2022) & (USD Million)
Table 33. North America Factor XIII Concentrate Revenue by Country (2023-2028) & (USD Million)
Table 34. North America Factor XIII Concentrate Sales by Type (2017-2022) & (K Units)
Table 35. North America Factor XIII Concentrate Sales by Type (2023-2028) & (K Units)
Table 36. North America Factor XIII Concentrate Sales by Application (2017-2022) & (K Units)
Table 37. North America Factor XIII Concentrate Sales by Application (2023-2028) & (K Units)
Table 38. Europe Factor XIII Concentrate Sales by Country (2017-2022) & (K Units)
Table 39. Europe Factor XIII Concentrate Sales by Country (2023-2028) & (K Units)
Table 40. Europe Factor XIII Concentrate Revenue by Country (2017-2022) & (USD Million)
Table 41. Europe Factor XIII Concentrate Revenue by Country (2023-2028) & (USD Million)
Table 42. Europe Factor XIII Concentrate Sales by Type (2017-2022) & (K Units)
Table 43. Europe Factor XIII Concentrate Sales by Type (2023-2028) & (K Units)
Table 44. Europe Factor XIII Concentrate Sales by Application (2017-2022) & (K Units)
Table 45. Europe Factor XIII Concentrate Sales by Application (2023-2028) & (K Units)
Table 46. Asia-Pacific Factor XIII Concentrate Sales by Region (2017-2022) & (K Units)
Table 47. Asia-Pacific Factor XIII Concentrate Sales by Region (2023-2028) & (K Units)
Table 48. Asia-Pacific Factor XIII Concentrate Revenue by Region (2017-2022) & (USD Million)
Table 49. Asia-Pacific Factor XIII Concentrate Revenue by Region (2023-2028) & (USD Million)
Table 50. Asia-Pacific Factor XIII Concentrate Sales by Type (2017-2022) & (K Units)
Table 51. Asia-Pacific Factor XIII Concentrate Sales by Type (2023-2028) & (K Units)
Table 52. Asia-Pacific Factor XIII Concentrate Sales by Application (2017-2022) & (K Units)
Table 53. Asia-Pacific Factor XIII Concentrate Sales by Application (2023-2028) & (K Units)
Table 54. South America Factor XIII Concentrate Sales by Country (2017-2022) & (K Units)
Table 55. South America Factor XIII Concentrate Sales by Country (2023-2028) & (K Units)
Table 56. South America Factor XIII Concentrate Revenue by Country (2017-2022) & (USD Million)
Table 57. South America Factor XIII Concentrate Revenue by Country (2023-2028) & (USD Million)
Table 58. South America Factor XIII Concentrate Sales by Type (2017-2022) & (K Units)
Table 59. South America Factor XIII Concentrate Sales by Type (2023-2028) & (K Units)
Table 60. South America Factor XIII Concentrate Sales by Application (2017-2022) & (K Units)
Table 61. South America Factor XIII Concentrate Sales by Application (2023-2028) & (K Units)
Table 62. Middle East & Africa Factor XIII Concentrate Sales by Region (2017-2022) & (K Units)
Table 63. Middle East & Africa Factor XIII Concentrate Sales by Region (2023-2028) & (K Units)
Table 64. Middle East & Africa Factor XIII Concentrate Revenue by Region (2017-2022) & (USD Million)
Table 65. Middle East & Africa Factor XIII Concentrate Revenue by Region (2023-2028) & (USD Million)
Table 66. Middle East & Africa Factor XIII Concentrate Sales by Type (2017-2022) & (K Units)
Table 67. Middle East & Africa Factor XIII Concentrate Sales by Type (2023-2028) & (K Units)
Table 68. Middle East & Africa Factor XIII Concentrate Sales by Application (2017-2022) & (K Units)
Table 69. Middle East & Africa Factor XIII Concentrate Sales by Application (2023-2028) & (K Units)
Table 70. Factor XIII Concentrate Raw Material
Table 71. Key Manufacturers of Factor XIII Concentrate Raw Materials
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Factor XIII Concentrate Typical Distributors
Table 75. Factor XIII Concentrate Typical Customers
List of Figures
Figure 1. Factor XIII Concentrate Picture
Figure 2. Global Factor XIII Concentrate Revenue Market Share by Type in 2021
Figure 3. 1000IU
Figure 4. 1600IU
Figure 5. Global Factor XIII Concentrate Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Global Factor XIII Concentrate Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Factor XIII Concentrate Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Factor XIII Concentrate Sales (2017-2028) & (K Units)
Figure 11. Global Factor XIII Concentrate Price (2017-2028) & (US$/Unit)
Figure 12. Global Factor XIII Concentrate Production Capacity (2017-2028) & (K Units)
Figure 13. Global Factor XIII Concentrate Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Factor XIII Concentrate Market Drivers
Figure 15. Factor XIII Concentrate Market Restraints
Figure 16. Factor XIII Concentrate Market Trends
Figure 17. Global Factor XIII Concentrate Sales Market Share by Manufacturer in 2021
Figure 18. Global Factor XIII Concentrate Revenue Market Share by Manufacturer in 2021
Figure 19. Factor XIII Concentrate Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Factor XIII Concentrate Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Factor XIII Concentrate Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Factor XIII Concentrate Sales Market Share by Region (2017-2028)
Figure 23. Global Factor XIII Concentrate Revenue Market Share by Region (2017-2028)
Figure 24. North America Factor XIII Concentrate Revenue (2017-2028) & (USD Million)
Figure 25. Europe Factor XIII Concentrate Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Factor XIII Concentrate Revenue (2017-2028) & (USD Million)
Figure 27. South America Factor XIII Concentrate Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Factor XIII Concentrate Revenue (2017-2028) & (USD Million)
Figure 29. Global Factor XIII Concentrate Sales Market Share by Type (2017-2028)
Figure 30. Global Factor XIII Concentrate Revenue Market Share by Type (2017-2028)
Figure 31. Global Factor XIII Concentrate Price by Type (2017-2028) & (US$/Unit)
Figure 32. Global Factor XIII Concentrate Sales Market Share by Application (2017-2028)
Figure 33. Global Factor XIII Concentrate Revenue Market Share by Application (2017-2028)
Figure 34. Global Factor XIII Concentrate Price by Application (2017-2028) & (US$/Unit)
Figure 35. North America Factor XIII Concentrate Sales Market Share by Type (2017-2028)
Figure 36. North America Factor XIII Concentrate Sales Market Share by Application (2017-2028)
Figure 37. North America Factor XIII Concentrate Sales Market Share by Country (2017-2028)
Figure 38. North America Factor XIII Concentrate Revenue Market Share by Country (2017-2028)
Figure 39. United States Factor XIII Concentrate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Factor XIII Concentrate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Factor XIII Concentrate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Factor XIII Concentrate Sales Market Share by Type (2017-2028)
Figure 43. Europe Factor XIII Concentrate Sales Market Share by Application (2017-2028)
Figure 44. Europe Factor XIII Concentrate Sales Market Share by Country (2017-2028)
Figure 45. Europe Factor XIII Concentrate Revenue Market Share by Country (2017-2028)
Figure 46. Germany Factor XIII Concentrate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Factor XIII Concentrate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Factor XIII Concentrate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Factor XIII Concentrate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Factor XIII Concentrate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Factor XIII Concentrate Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Factor XIII Concentrate Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Factor XIII Concentrate Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Factor XIII Concentrate Revenue Market Share by Region (2017-2028)
Figure 55. China Factor XIII Concentrate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Factor XIII Concentrate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Factor XIII Concentrate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Factor XIII Concentrate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Factor XIII Concentrate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Factor XIII Concentrate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Factor XIII Concentrate Sales Market Share by Type (2017-2028)
Figure 62. South America Factor XIII Concentrate Sales Market Share by Application (2017-2028)
Figure 63. South America Factor XIII Concentrate Sales Market Share by Country (2017-2028)
Figure 64. South America Factor XIII Concentrate Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Factor XIII Concentrate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Factor XIII Concentrate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Factor XIII Concentrate Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Factor XIII Concentrate Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Factor XIII Concentrate Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Factor XIII Concentrate Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Factor XIII Concentrate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Factor XIII Concentrate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Factor XIII Concentrate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Factor XIII Concentrate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Factor XIII Concentrate in 2021
Figure 76. Manufacturing Process Analysis of Factor XIII Concentrate
Figure 77. Factor XIII Concentrate Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のプロテインC濃縮物市場2022年：市場規模予測（～2028年）
  • 世界のフォン・ヴィレブランド因子（組換え）市場2022年：市場規模予測（～2028年）
  • 世界の心停止輸液用無菌濃縮液市場2022年：市場規模予測（～2028年）
  • 凝固第VIIa因子のグローバル市場展望 2023年-2029年：ノボセブン、ノボセブンRT
  • 世界の組換え活性化凝固第VII因子市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19312 )"世界の第XIII因子濃縮物市場2022年：市場規模予測（～2028年）" (英文：Global Factor XIII Concentrate Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。